Selective activation of tumor necrosis factor receptor 2 induces anti ‐inflammatory responses and alleviates experimental arthritis

ConclusionsSummarizing, our data argue for the use of TNFR2‐selective therapeutics as an effective approach in treating arthritic disease and possibly other inflammatory and autoimmune diseases.This article is protected by copyright. All rights reserved.

Source: Arthritis and Rheumatism - January 17, 2018 Category: Rheumatology Authors: Roman Fischer, Marcel Proske, Ma ëlle Duffey, Hubert Stangl, George F. Martinez, Nathalie Peters, Alexandra Kraske, Rainer H. Straub, John R. Bethea, Roland E. Kontermann, Klaus Pfizenmaier Tags: Full Length Source Type: research